Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Diabetes Care. 2010 Dec;33(12):2538-42. doi: 10.2337/dc10-0939. Epub 2010 Sep 15.
To reveal the influence of preoperative factors on the prognosis of patients undergoing percutaneous transluminal angioplasty (PTA) for critical limb ischemia (CLI).
We recruited 278 Japanese patients who underwent PTA for CLI between 2003 and 2009. The outcome measures were mortality and major amputation. Cox proportional hazards regression analyses were performed.
The prevalence of diabetes was 71%, and A1C was 7.0 ± 1.4%. The follow-up period was 90 ± 72 weeks, and 48 patients underwent major amputations and 89 died. The presence of diabetes in the whole population and A1C level in the diabetic population had no influence on morality; rather, mortality was associated with age (P = 0.007), impaired activities of daily living (P < 0.001), hemodialysis (P < 0.001), and albumin level (P = 0.010). In contrast, the presence of diabetes and A1C level had significant association with major amputation (P = 0.012 and P = 0.007, respectively). The quartile analysis showed that diabetic subjects with an A1C ≥ 6.8%, but not <6.8%, had a significantly higher risk of major amputation than nondiabetic subjects. The adjusted hazard ratio of diabetes with A1C ≥ 6.8% was 2.907 (95% CI 1.606-5.264) (P < 0.001).
Diabetes with poor glycemic control is associated with major amputation, but not mortality, in CLI patients undergoing PTA. Prognostic indicators seem somewhat different between survival and limb salvage in the population.
揭示术前因素对接受经皮腔内血管成形术(PTA)治疗的严重肢体缺血(CLI)患者预后的影响。
我们招募了 278 名 2003 年至 2009 年间接受 PTA 治疗 CLI 的日本患者。结局指标为死亡率和主要截肢率。采用 Cox 比例风险回归分析。
糖尿病患病率为 71%,糖化血红蛋白(A1C)为 7.0±1.4%。随访期为 90±72 周,48 例患者接受了主要截肢,89 例患者死亡。在整个人群中,糖尿病的存在和糖尿病患者的 A1C 水平对死亡率没有影响;相反,死亡率与年龄(P=0.007)、日常生活活动能力受损(P<0.001)、血液透析(P<0.001)和白蛋白水平(P=0.010)相关。相比之下,糖尿病的存在和 A1C 水平与主要截肢有显著相关性(P=0.012 和 P=0.007)。四分位分析显示,A1C≥6.8%但<6.8%的糖尿病患者发生主要截肢的风险明显高于非糖尿病患者。A1C≥6.8%的糖尿病患者的调整后危险比为 2.907(95%CI 1.606-5.264)(P<0.001)。
接受 PTA 治疗的 CLI 患者中,血糖控制不佳的糖尿病与主要截肢有关,与死亡率无关。人群中生存和肢体保存的预后指标似乎有些不同。